<!DOCTYPE html>
<html>
<head>
    <title>In&#xAD;dia&#x2019;s drug ex&#xAD;perts give nod for emer&#xAD;gency use of As&#xAD;traZeneca, lo&#xAD;cal vac&#xAD;cines - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20210103/281685437467582" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>In&#xAD;dia&#x2019;s drug ex&#xAD;perts give nod for emer&#xAD;gency use of As&#xAD;traZeneca, lo&#xAD;cal vac&#xAD;cines</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20210103/textview" title="The Straits Times - 2021-01-03"><time>2021-01-03</time></a>
        - <span>THE BIG STORY</span>
        - <span role="byline"></span>
    </section>

    <p>NEW DELHI • Ex­perts at In­dia’s drug reg­u­la­tors have rec­om­mended for emer­gency use two coro­n­avirus vac­cines, one de­vel­oped by As­traZeneca and Ox­ford Univer­sity and the other backed by a state-run in­sti­tute, the govern­ment said yes­ter­day.</p>
    <p>A govern­ment min­is­ter said ear­lier that the As­traZeneca-Ox­ford vac­cine – pro­duced by the Serum In­sti­tute of In­dia (SII) – had been given the green light on Fri­day, paving the way for a huge im­mu­ni­sa­tion cam­paign in the world’s se­cond-most-pop­u­lous coun­try.</p>
    <p>The govern­ment said the fi­nal de­ci­sion on the two vac­cines would be made by the chief of the Cen­tral</p>
    <p>Drugs Stan­dard Con­trol Or­gan­i­sa­tion (CDSCO). That process is ex­pected to be a for­mal­ity, given the ur­gency for a vac­cine in the coun­try with the high­est num­ber of coro­n­avirus in­fec­tions in the world af­ter the United States.</p>
    <p>The other vac­cine, known as Co­vaxin, has been de­vel­oped lo­cally by Bharat Biotech and the govern­ment-run In­dian Coun­cil of Med­i­cal Re­search. Cit­ing sources, Reuters re­ported on Fri­day that the shot could be ap­proved, though lit­tle is known about the re­sults of its clin­i­cal tri­als.</p>
    <p>“Grant of per­mis­sion for re­stricted use in emer­gency sit­u­a­tion in public interest as an abun­dant pre­cau­tion, in clin­i­cal trial mode, spe­cially in the con­text of in­fec­tion by mutant strains,” the govern­ment cited the ex­perts’ rec­om­men­da­tion for Co­vaxin, re­fer­ring to the new strain of the virus first de­tected in Bri­tain.</p>
    <p>For the As­traZeneca-Ox­ford vac­cine, the ap­proval was “sub­ject to mul­ti­ple reg­u­la­tory con­di­tion­al­i­ties”, it said, with­out giv­ing de­tails.</p>
    <p>In­for­ma­tion and Broad­cast­ing Min­is­ter Prakash Javadekar told re­porters ear­lier that two other vac­cines were wait­ing to be ap­proved – Zy­dus Cadila’s ZyCoV-D and Rus­sia’s Sput­nik V, which are both on trial in In­dia.</p>
    <p>“In­dia is per­haps the only coun­try where four vac­cines are get­ting ready,” he said.</p>
    <p>The CDSCO is ex­pected to an­nounce the dosage and other de­tails about the shot later. SII had ap­plied for a two full-dose regime about 28 days apart. The coun­try hopes to in­oc­u­late 300 mil­lion of its 1.35 bil­lion peo­ple in the first six to eight months of this year.</p>

    <div>
        <picture>
            <img src="https://i.prcdn.co/img?regionKey=2amibLJ%2fKjwnWJUMxzJ3aQ%3d%3d" />
        </picture>
        <span role="byline">PHOTO: BLOOMBERG</span>
        <p data-role="text">A regis&#xAD;tra&#xAD;tion counter for a na&#xAD;tion&#xAD;wide trial of a Covid-19 vac&#xAD;cine de&#xAD;liv&#xAD;ery sys&#xAD;tem at a vac&#xAD;ci&#xAD;na&#xAD;tion cen&#xAD;tre in Delhi yes&#xAD;ter&#xAD;day.</p>
    </div>

</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
